Helping you make wiser investment decisions

BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029: report

March 16, 2022 fkansteiner



BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029: report
fkansteiner
Wed, 03/16/2022 – 13:19



Source link